The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The index has shown a price loss of -20.65% this year. Over the last six
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded an increase of 19.41%. However, over the last six months, the performance has been weaker
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. NanoVibronix Inc’s current trading price is -11.74% away from its 52-week high, while its distance from the 52-week low is 542.19%. The stock’s price range
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded a decrease of -66.01%. However, over the last six months,
NanoVibronix has submitted its finding of UroShield to the National Institute for Health and Care Excellence (NICE). Shares of NanoVibronix, Inc. (NAOV) is rallying today on the positive findings of its UroShield® device on patients with an evaluation time period of over two years. The
All rights reserved © 2024, Powered By Smart TechOne
